文献
J-GLOBAL ID:202202249588073071
整理番号:22A0138922
肝機能障害発症後の治療中止の医師決定に影響する要因:イグラチモドの全症例市販後調査の事後分析
Factors influencing physician decisions to discontinue treatment after onset of liver dysfunction: Post-hoc analysis of an all-case post-marketing surveillance study of iguratimod
著者 (5件):
Ishiguro Naoki
(Department of Orthopaedic Surgery, Graduate School & Faculty of Medicine, Nagoya University, Nagoya, Japan)
,
Shibata Kai
(Clinical Planning and Development Department, Medical HQs, Eisai Co., Ltd, Tokyo, Japan)
,
Yoshimura Akiko
(Clinical Planning and Development Department, Medical HQs, Eisai Co., Ltd, Tokyo, Japan)
,
Ikeuchi Satoshi
(Clinical Planning and Development Department, Medical HQs, Eisai Co., Ltd, Tokyo, Japan)
,
Ishii Mika
(Clinical Planning and Development Department, Medical HQs, Eisai Co., Ltd, Tokyo, Japan)
資料名:
Modern Rheumatology
(Modern Rheumatology)
巻:
30
号:
4
ページ:
633-639
発行年:
2020年07月
JST資料番号:
L5142A
ISSN:
1439-7595
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)